Literature DB >> 16194071

Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics.

Suzanne R Kalb1, Michael C Goodnough, Carl J Malizio, James L Pirkle, John R Barr.   

Abstract

Botulinum neurotoxin (BoNT) causes the disease botulism, which can be lethal if untreated. Rapid determination of exposure to BoNT is an important public health goal. Previous work in our laboratory focused on the development of Endopep-MS, a mass spectrometry-based endopeptidase method for detecting and differentiating BoNT in buffer. This method can rapidly determine the presence of BoNT in a sample and differentiate the toxin type of BoNT present but does not yield additional information about the subtype. We now describe here the application of Endopep-MS to detect BoNT A in a spiked milk sample. This work also describes subtype identification achieved through mass spectrometric analysis of the protein toxin itself and does not require the presence of DNA from the toxin-producing bacteria. Tryptic digests of A1 and A2 subtypes of BoNT were analyzed by mass spectrometry, and peptides unique to either the A1 or A2 subtype were subjected to tandem mass spectrometry analysis to confirm their identities. Finally, subtype identification through mass spectrometric analysis was performed on BoNT A isolated from spiked milk. In its entirety, this method would allow for analysis of BoNT with toxin type identification in a few hours and subtype identification within 24 h.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194071     DOI: 10.1021/ac0511748

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  24 in total

1.  The case of botulinum toxin in milk: experimental data.

Authors:  Oliver G Weingart; Tanja Schreiber; Conny Mascher; Diana Pauly; Martin B Dorner; Thomas F H Berger; Charlotte Egger; Frank Gessler; Martin J Loessner; Marc-Andre Avondet; Brigitte G Dorner
Journal:  Appl Environ Microbiol       Date:  2010-04-02       Impact factor: 4.792

2.  Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics.

Authors:  Suzanne R Kalb; John R Barr
Journal:  Rev Anal Chem       Date:  2013-08       Impact factor: 3.067

3.  Subtyping botulinum neurotoxins by sequential multiple endoproteases in-gel digestion coupled with mass spectrometry.

Authors:  Dongxia Wang; Jakub Baudys; Jon Rees; Kristin M Marshall; Suzanne R Kalb; Bryan A Parks; Louis Nowaczyk; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2012-05-21       Impact factor: 6.986

4.  New approach for the rational selection of markers to identify botulinum toxins.

Authors:  Osnat Rosen; Liron Feldberg; Eyal Dor; Ran Zichel
Journal:  Arch Toxicol       Date:  2021-02-10       Impact factor: 5.153

5.  Toxin detection in patients' sera by mass spectrometry during two outbreaks of type A Botulism in France.

Authors:  Christelle Mazuet; Eric Ezan; Hervé Volland; Michel Robert Popoff; François Becher
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

6.  Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.

Authors:  F Mark Dunning; Timothy M Piazza; Füsûn N Zeytin; Ward C Tucker
Journal:  J Vis Exp       Date:  2014-03-03       Impact factor: 1.355

7.  Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5.

Authors:  Suzanne R Kalb; Jakub Baudys; Theresa J Smith; Leonard A Smith; John R Barr
Journal:  Anal Chem       Date:  2014-03-13       Impact factor: 6.986

8.  The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop review: assays and detection.

Authors:  C Shone; J Ferreira; A Boyer; N Cirino; C Egan; E Evans; J Kools; S Sharma
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

9.  Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes.

Authors:  Sean A Gray; John R Barr; Suzanne R Kalb; James D Marks; Cheryl L Baird; Gerard A Cangelosi; Keith D Miller; Michael J Feldhaus
Journal:  Biotechnol Bioeng       Date:  2011-05-12       Impact factor: 4.530

10.  Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex.

Authors:  Ellen R Goldman; George P Anderson; Jerry Conway; Laura J Sherwood; Melissa Fech; BaoHan Vo; Jinny L Liu; Andrew Hayhurst
Journal:  Anal Chem       Date:  2008-10-24       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.